← Back to Search

Software Program

ROTEM Interpretation Software for Hemostatic Disorders

N/A
Recruiting
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year of data collection
Awards & highlights

Study Summary

This trial tests a new software to help doctors make more accurate decisions about blood clotting. #medtech #bloodclotting

Who is the study for?
This trial is for current residents and attending physicians in the University of Utah's Department of Anesthesiology, who have varying levels of experience with thromboelastography. Those not actively part of this department or unwilling to consent are excluded.Check my eligibility
What is being tested?
The study is evaluating a new software designed to help doctors interpret ROTEM (rotational thromboelastometry) tests more accurately. These tests measure how well blood clots in patients with clotting disorders.See study design
What are the potential side effects?
Since the intervention involves only the use of a software program for interpreting test results, there are no direct physical side effects associated with its use.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year of data collection
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year of data collection for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Diagnostic accuracy

Trial Design

1Treatment groups
Experimental Treatment
Group I: Software TutorialExperimental Treatment1 Intervention
Participants will be asked to interpret a series of ROTEM studies before and after a tutorial on a novel ROTEM interpretation software.

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,778,589 Total Patients Enrolled

Media Library

Novel ROTEM interpretation software (Software Program) Clinical Trial Eligibility Overview. Trial Name: NCT05591014 — N/A
Blood Clotting Disorder Research Study Groups: Software Tutorial
Blood Clotting Disorder Clinical Trial 2023: Novel ROTEM interpretation software Highlights & Side Effects. Trial Name: NCT05591014 — N/A
Novel ROTEM interpretation software (Software Program) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05591014 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still openings available for participants in this trial?

"The clinical trial is actively recruiting patients, evidenced by its recent updates on April 25th 2023. This medical study was initially posted to the website April 13th of this same year."

Answered by AI

How many subjects are actively participating in this investigation?

"Yes, the information on clinicaltrials.gov reveals that this experiment is actively recruiting participants since it was first uploaded to their website in April 13th 2023 and last modified 25 days later. The study requires 100 patients from one location."

Answered by AI
~40 spots leftby Dec 2024